OREANDA-NEWS. April 04, 2012. The Federal Antimonopoly Service (FAS Russia) drafted and successfully advocated a norm regulating substitutability of medical products to be added to the Federal Law “On Fundamental Healthcare Principles in the Russian Federation”. The norm is incorporated in Article 38 of the Law, reported the press-centre of FAS Russia.

Under Article 38 of the Law, from 1st July 2012 Roszdravnadzor (the Federal Service for Supervision of Public Health and Social Development) will have to determine sustainability of medical products and include this information in the State Register of Medical Products and Organizations Involved in Production and Fabrication of Medical Products.

The norm of the law will help minimizing incidents when technical assignments for tender documentation are drafted to fit a particular producer (supplier) and enable allowing maximum number of procurement participants, offering substitute medical products, to take part in tenders, which will create real opportunities for reducing prices in course of tenders funded through the budget.

“The new legal norm will enable FAS to analyze the market of medical products within a short period exercising state control over economic concentration and to consider whether FAS should initiate cases upon signs of violating the antimonopoly law”, pointed out Deputy Head of FAS Department for Control over Social Sphere and Trade, Ms. Nadezhda Sharavskaya.